Literature DB >> 12943369

Proinflammatory cytokine expression in the endolymphatic sac during inner ear inflammation.

Hitoshi Satoh1, Gary S Firestein, Peter B Billings, Jeffrey P Harris, Elizabeth M Keithley.   

Abstract

The inner ear is capable of rapidly mounting an immune response that can ultimately lead to cochlear degeneration and permanent hearing loss. The role of the endolymphatic sac in this immune process is not clear. In order to investigate the cytokine expression of cells within the endolymphatic sac, a secondary inner ear immune response to keyhole limpet hemocyanin (KLH) was created in mice. The animals were sacrificed 3-48 h and 7 days following initiation of the immune response. The cochleas and endolymphatic sacs were assayed by immunocytochemistry for IL-1beta, TNFalpha, and IL-6. Three hours after KLH challenge of the scala tympani, the perisaccular tissue of the endolymphatic sac contained more inflammatory cells than the scala tympani or endolymphatic sac lumen. Only a few of these cells, however, expressed the proinflammatory cytokines IL-1beta and TNFalpha between 3 and 12 h after KLH injection. On the other hand, TNFalpha, which plays an important role in the cochlear secondary immune response, was expressed in cells in the endolymphatic sac lumen. The maximum percentage of cells expressing TNFalpha was seen later than in the scala tympani. Animals treated with systemic injection of the TNF blocker, etanercept, showed a reduction in the number of cells in the endolymphatic sac lumen. It is concluded that the cells in the endolymphatic sac lumen contribute to the amplification of the adaptive immune response by expressing TNFalpha, while the infiltration of cells into the perisaccular connective tissue is part of the nonspecific, innate, cochlear immune response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12943369      PMCID: PMC3202716          DOI: 10.1007/s10162-002-3025-7

Source DB:  PubMed          Journal:  J Assoc Res Otolaryngol        ISSN: 1438-7573


  22 in total

1.  Clinical implications of inflammatory cytokines in the cochlea: a technical note.

Authors:  Joe C Adams
Journal:  Otol Neurotol       Date:  2002-05       Impact factor: 2.311

2.  Connection between the inner ear and the lymphatic system.

Authors:  K Yimtae; H Song; P Billings; J P Harris; E M Keithley
Journal:  Laryngoscope       Date:  2001-09       Impact factor: 3.325

3.  Immunohistochemical analysis of proliferating cells in a sterile labyrinthitis animal model.

Authors:  M C Chen; J P Harris; E M Keithley
Journal:  Laryngoscope       Date:  1998-05       Impact factor: 3.325

4.  Lymphocyte-macrophage activity in the endolymphatic sac. An ultrastructural study of the rugose endolymphatic sac in the guinea pig.

Authors:  H Rask-Andersen; J Stahle
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  1979       Impact factor: 1.538

5.  Nature of blood-labyrinth barrier in experimental conditions.

Authors:  S K Juhn; L P Rybak; S Prado
Journal:  Ann Otol Rhinol Laryngol       Date:  1981 Mar-Apr       Impact factor: 1.547

6.  Immunodefence of the inner ear? Lymphocyte-macrophage interaction in the endolymphatic sac.

Authors:  H Rask-Andersen; J Stahle
Journal:  Acta Otolaryngol       Date:  1980 Mar-Apr       Impact factor: 1.494

7.  T cells infiltrating from the systemic circulation proliferate in the endolymphatic sac.

Authors:  H Iwai; K Tomoda; K Sugiura; M Inaba; S Ikehara; T Yamashita
Journal:  Ann Otol Rhinol Laryngol       Date:  1999-12       Impact factor: 1.547

8.  Autoimmune sensorineural hearing loss.

Authors:  B F McCabe
Journal:  Ann Otol Rhinol Laryngol       Date:  1979 Sep-Oct       Impact factor: 1.547

9.  Tumor necrosis factor-alpha, an initiator, and etanercept, an inhibitor of cochlear inflammation.

Authors:  Hitoshi Satoh; Gary S Firestein; Peter B Billings; Jeffrey P Harris; Elizabeth M Keithley
Journal:  Laryngoscope       Date:  2002-09       Impact factor: 3.325

10.  Steroid-responsive bilateral sensorineural hearing loss and immune complexes.

Authors:  J Kanzaki; T Ouchi
Journal:  Arch Otorhinolaryngol       Date:  1981
View more
  42 in total

1.  Biomarkers of Systemic Inflammation and Risk of Incident Hearing Loss.

Authors:  Shruti Gupta; Sharon G Curhan; Gary C Curhan
Journal:  Ear Hear       Date:  2019 Jul/Aug       Impact factor: 3.570

2.  Astragaloside IV Inhibits the Inflammatory Injury of Chicken Type II Pneumocytes Induced by Avian Pathogenic Escherichia coli.

Authors:  Li-Yan Zhang; Peng-Fei Yi; Xun Guo; Shuai-Cheng Wu; Yun-Xing Fu; Cui Zhang; Ben-Dong Fu; Hai-Qing Shen; Xu-Bin Wei
Journal:  Inflammation       Date:  2016-10       Impact factor: 4.092

3.  Endolymphatic sac involvement in bacterial meningitis.

Authors:  Martin Nue Møller; Christian Brandt; Christian Østergaard; Per Caye-Thomasen
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-01-23       Impact factor: 2.503

Review 4.  Immunosuppressive therapy for autoimmune inner ear disease.

Authors:  Maria C Buniel; Katie Geelan-Hansen; Peter C Weber; Vincent K Tuohy
Journal:  Immunotherapy       Date:  2009-05       Impact factor: 4.196

5.  Treatment of Menière's Disease.

Authors:  Jeffrey D Sharon; Carolina Trevino; Michael C Schubert; John P Carey
Journal:  Curr Treat Options Neurol       Date:  2015-04       Impact factor: 3.598

6.  The melanocortin 1 receptor (MC1R) inhibits the inflammatory response in Raw 264.7 cells and atopic dermatitis (AD) mouse model.

Authors:  Wei Chen; Jianping Li; Hai'e Qu; Zhou Song; Zhanqing Yang; Jinlong Huo; Huaizhi Jiang; Qinghua Huang; Meixia Huo; Bo Liu; Qiaoling Zhang
Journal:  Mol Biol Rep       Date:  2012-10-23       Impact factor: 2.316

7.  Cepharanthine, an alkaloid from Stephania cepharantha Hayata, inhibits the inflammatory response in the RAW264.7 cell and mouse models.

Authors:  Hailong Huang; Guixue Hu; Chunfeng Wang; Hao Xu; Xiaoqing Chen; Aidong Qian
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

8.  Evidence that cisplatin-induced auditory damage is attenuated by downregulation of pro-inflammatory cytokines via Nrf2/HO-1.

Authors:  HongSeob So; HyungJin Kim; Yunha Kim; Eunsook Kim; Hyun-Ock Pae; Hun-Taeg Chung; Hye-Jung Kim; Kang-Beom Kwon; Kang-Min Lee; Haa-Yung Lee; Sung-Kyun Moon; Raekil Park
Journal:  J Assoc Res Otolaryngol       Date:  2008-06-27

9.  Protective effects of kaempferol on lipopolysaccharide-induced mastitis in mice.

Authors:  Rongfeng Cao; Kaiqiang Fu; Xiaopei Lv; Weishi Li; Naisheng Zhang
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

10.  TNFalpha blockers do not improve the hearing recovery obtained with glucocorticoid therapy in an autoimmune experimental labyrinthitis.

Authors:  David Lobo; Almudena Trinidad; José Ramón García-Berrocal; Jose María Verdaguer; Rafael Ramírez-Camacho
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-03-18       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.